Monoclonal Antibodies


More Treatment Topics

Chemotherapy | Immunotherapy | Radiotherapy | Treatment

According to a recent randomized controlled trial, rituximab increased the duration of remission

The results of a pair of long-term survival studies indicate the therapeutic value of

Biopharmaceutical company MorphoSys is reporting that it has been given fast track

The drug Rituximab is showing to slow symptoms of lymphoma, but does it increase survival:

According to findings to be reported at the annual meeting of the American Society of Clinical

Pharmaceutical giant Pfizer is withdrawing the monoclonal antibody

Today the US Food and Drug Administration granted accelerated approval for Darzalex (

TG Therapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has

At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company

According to research presented at the annual meeting of the American Society of Hematology,

In case you're unfamiliar, the Rituxan Retirement Plan (RRP) is an inside joke amongst

Spectrum Pharmaceuticals is launching a new patient campaign surrounding the company's lead

Spectrum Pharmaceuticals Inc, the biotech firm that owns and makes the

The US Food and Drug Administration has approved the use of the anti-CD20 monoclonal antibody

Sitemap